Loading...
Domestic
Equity
Passive

RISE Healthcare (253280)

Update : 2026.07.17

NAV

12,283KRW

-0.04하락 (-%)

Market Price per share (KRW)

12,305KRW

-160하락 (-1.28%)

※ t-1 last price

trading volume

4,149shares

AUM

KRW 7.3billion

RISE Healthcare (253280)

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.07.17
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280)
FnGuide HealthCare Index 2016.09.23 50,000 7,369,803,608
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,305
※ t-1 last price
12,283 4,149
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280)
FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
7,369,803,608 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,305
※ t-1 last price
12,283
Trading Volume (shares)
4,149
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-07-17
Rank , Name, proportion table
Rank Name Weight (%)
1 SAMSUNG BIOLOGICS 11.59
2 Celltrion 11.50
3 Alteogen 9.02
4 HLB 5.76
5 Yuhan 5.39
6 ABL Bio 4.71
7 SKBP 4.39
8 LCB 4.12
9 SCD 3.74
10 SAMSUNG EPIS HOLDINGS 3.72

proportion by sectors

*The proportion of investment stocks

Update : 2026.07.17
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2026-04-30 2026-05-06 25
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-07-17

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV -12.84 -29.54 -30.48 -21.11 17.14 -26.94 21.29
Benchmark Index -12.98 -29.98 -31.02 -21.56 16.88 -27.39 21.54
Outperformance 0.14 0.44 0.53 0.44 0.26 0.44 -0.25

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.07.16 12,305 -1.283하락 12,283.1 -0.980하락 10,357.47
2026.07.15 12,465 5.101상승 12,404.7 4.707상승 10,357.52
2026.07.14 11,860 -3.380하락 11,846.99 -3.704하락 10,357.56
2026.07.13 12,275 -4.026하락 12,302.78 -3.672하락 10,357.61
2026.07.10 12,790 0.431상승 12,771.92 0.200상승 10,357.75
2026.07.09 12,735 -1.849하락 12,746.3 -1.760하락 10,357.8
2026.07.08 12,975 -4.630하락 12,974.74 -4.499하락 10,357.85
2026.07.07 13,605 3.029상승 13,586.08 2.309상승 10,357.9
2026.07.06 13,205 -3.260하락 13,279.37 -3.040하락 10,357.95
2026.07.03 13,650 -0.036하락 13,695.87 0.024상승 10,358.09
2026.07.02 13,655 -1.443하락 13,692.55 -1.586하락 10,358.14
2026.07.01 13,855 -0.395하락 13,913.33 0.189상승 10,358.19
2026.06.30 13,910 -3.469하락 13,887.08 -3.954하락 10,358.24
2026.06.29 14,410 10.463상승 14,458.81 10.679상승 10,358.29
2026.06.26 13,045 -5.505하락 13,063.82 -5.026하락 10,356.76
2026.06.25 13,805 -0.108하락 13,755.16 -0.326하락 10,356.81
2026.06.24 13,820 6.965상승 13,800.26 6.999상승 10,356.85
2026.06.23 12,920 -3.546하락 12,897.45 -4.132하락 10,356.9
2026.06.22 13,395 -2.261하락 13,453.4 -1.635하락 10,356.95
2026.06.19 13,705 -2.939하락 13,677.15 -2.949하락 10,357.09

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 SAMSUNG BIOLOGICS KR7207940008 52 11.59 71,916,000
2 Celltrion KR7068270008 406 11.5 71,334,200
3 Alteogen KR7196170005 194 9.02 55,969,000
4 HLB KR7028300002 1,030 5.76 35,741,000
5 Yuhan KR7000100008 481 5.39 33,429,500
6 ABL Bio KR7298380007 368 4.71 29,182,400
7 SKBP KR7326030004 348 4.39 27,213,600
8 LCB KR7141080002 230 4.12 25,530,000
9 SCD KR7000250001 121 3.74 23,183,600
10 SAMSUNG EPIS HOLDINGS KR70126Z0002 57 3.72 23,056,500
11 HanmiPharm KR7128940004 55 3.41 21,147,500
12 PharmaResearch KR7214450009 58 3.06 18,995,000
13 HANALL BIOPHARMA KR7009420001 306 2.68 16,646,400
14 ST Pharm KR7237690003 113 2.24 13,899,000
15 L&C BIO KR7290650001 158 1.83 11,344,400
16 Hugel KR7145020004 46 1.73 10,741,000
17 CLASSYS KR7214150005 232 1.7 10,567,600
18 SEEGENE KR7096530001 278 1.31 8,131,500
19 SKBS KR7302440003 230 1.31 8,096,000
20 원화예금 KRD010010001 7,887,490 1.27 7,887,490
21 ORUM KR7475830006 161 1.26 7,792,400
22 Celltrionph KR7068760008 178 1.15 7,137,800
23 Lunit KR7328130000 608 0.98 6,104,320
24 Pharmicell KR7005690003 485 0.94 5,810,300
25 GC Biopharma Corp. KR7006280002 48 0.94 5,832,000
26 Hanmi Science KR7008930000 176 0.92 5,693,600
27 CHA Biotech KR7085660009 520 0.8 4,955,600
28 HK inno.N KR7195940002 123 0.78 4,833,900
29 CHONGKUNDANG KR7185750007 69 0.76 4,685,100
30 DAEWOONG PHARM KR7069620003 39 0.75 4,637,100
31 DongKook Pharm KR7086450004 205 0.63 3,907,300
32 MedyTox KR7086900008 47 0.55 3,402,800
33 i-SENS KR7099190001 189 0.47 2,893,590
34 ShinpoongPharm KR7019170000 345 0.45 2,801,400
35 JWPHARMA KR7001060003 116 0.45 2,813,000
36 ILDONG PHARM KR7249420001 183 0.42 2,633,370
37 KLS KR7102940004 65 0.41 2,518,750
38 DENTIUM KR7145720009 57 0.37 2,302,800
39 EuBio KR7206650004 271 0.36 2,214,070
40 CUREXO KR7060280005 253 0.34 2,125,200
41 T&L KR7340570001 40 0.34 2,100,000
42 WONTECH KR7336570007 374 0.33 2,068,220
43 HLBPHARMA KR7047920004 242 0.33 2,076,360
44 GC Corp. KR7005250006 188 0.29 1,829,240
45 Binex KR7053030003 250 0.28 1,722,500
46 Huons Global KR7084110006 47 0.21 1,332,450
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.